Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Whole Genome Sequencing Testing Is Available At The New York Genome Center

    Jan 20, 2017, 05:05 AM by Michael Croft

    Bio-IT World | Whole genome sequencing testing, available at the New York Genome Center, brings precision medicine one step closer to reality. Researchers, physicians, and patients are finding new ways to use the information encoded in genes. 

    Full story
  • China Aims To Build World’s First Exascale Supercomputer Prototype By End Of 2017

    Jan 19, 2017, 14:31 PM by Michael Croft
    The Verge | Building supercomputers is a digital arms race, and China is moving quickly to solidify its lead. This year the government has set its sights on completing the world's first prototype exascale computer; a machine capable of making a billion calculations per second.
    Full story
  • AgileBio announces a new mobile app: LabCollector Stock Manager

    Jan 19, 2017, 06:15 AM by Michael Croft
    SAN DIEGO, CA, UNITED STATES - Jan 19, 2017 - The LabCollector Stock Manager will allow labs to scan barcoded items and easily track movements into and out of their stockx
    Full story
  • Whole genome analysis leads to faster diagnosis and cost benefits

    Jan 19, 2017, 04:48 AM by Michael Croft
    CAMBRIDGE, UK - Jan 19, 2017 - Whole genome analysis (WGA) enables rapid diagnosis of rare disease, ensuring that an appropriate course of management and treatment can be administered, possibly within days for acute neonatal cases, cutting the cost of intensive care and potentially saving lives
    Full story
  • Obama Administration Decides Consent Of Patients Not Needed To Study Their Blood DNA

    Jan 18, 2017, 21:06 PM by Michael Croft
    NPR.org | In its update of ethics rules aimed at protecting patients, the Obama administration decided against a provision that scientists said would hinder research. Consumer advocates aren't happy.
    Full story
  • AI Software Learns to Make AI Software

    Jan 18, 2017, 15:23 PM by Michael Croft
    MIT Technology Review | Google and others think software that learns to learn could take over some work done by AI experts.
    Full story
  • Where The Money Is: 2016 Edition

    Jan 18, 2017, 09:37 AM by Michael Croft
    ENDPOINTS NEWS | Thomson Reuters dug up investment numbers for all of the top 100 VCs investing in biotech, and Endpoints News ranked them. Flagship, Third Rock, New Enterprise Associates, and Arch Venture are the top four, and many of the top four players remain focused on early stage investment.
    Full story
  • Congenica expands in North America with strategic appointment

    Jan 17, 2017, 11:07 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Jan 17, 2017 - Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha O’Brien as its Chief Business Officer
    Full story
  • Novogene Purchases 10 PacBio Sequel Systems

    Jan 16, 2017, 15:35 PM by Michael Croft
    Bio-IT World Brief | Novogene today announced its intention to purchase 10 Sequel Systems for whole genome sequencing, Iso-Seq annotation and targeted sequencing services from Pacific Biosciences.
    Full story
  • The Stem-Cell Revolution Is Coming — Slowly

    Jan 16, 2017, 13:40 PM by Michael Croft
    The New York Times | Where are the miracle treatments we were promised? A Nobel Prize-winning scientist explains.
    Full story
  • Biotech IPO Master Is Still Setting Up New Biotechs And Hatching More Deals

    Jan 13, 2017, 14:08 PM by Michael Croft
    ENDPOINTS NEWS | Vivek Ramaswamy blindsided the biotech industry with a record-setting IPO for the mystery biotech Axovant. The one-time hedge fund maestro turned drug entrepreneur has set up three more companies and taken one of them public at near supersonic speed, all while busily in-licensing drugs from a growing list of suppliers.
    Full story
  • IDBS launches The E-WorkBook Cloud: combining the most powerful R&D software platform with the benefits and flexibility of the cloud

    Jan 13, 2017, 07:38 AM by Michael Croft
    BOSTON & LONDON, US & UK - Jan 12, 2017 - IDBS has today launched The E-WorkBook Cloud, an enterprise, Cloud-based platform designed specifically to meet the future challenges of scientific and R&D data management
    Full story
  • JP Morgan News Round Up

    Jan 12, 2017, 12:25 PM by Michael Croft

    Bio-IT World Brief | The JP Morgan Healthcare Conference was held this week in San Francisco, kicking off 2017 with news and deals and product announcements. Many presentations were webcast. Here are some of the highlights and news bits we’ve collected over the past three days.

    Full story
  • Creative Peptides Added Specific Peptide Synthesis and Related Services

    Jan 11, 2017, 04:52 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Jan 11, 2017 - Creative Peptides optimized its synthesis services by adding more specific peptide synthesis, and three categories are included-GMP peptide synthesis, glycopeptides synthesis, Cell-Penetrating Peptides Synthesis
    Full story
  • Certara Launches Version 16 of its Simcyp Population-based Simulator

    Jan 10, 2017, 08:23 AM by Michael Croft
    PRINCETON, NJ - Jan 10, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it has released version 16 of its Simcyp® Population-based Simulator
    Full story
  • Illumina Launches NovaSeq Sequencers, Aiming To Replace 1900 Sequencers

    Jan 9, 2017, 19:55 PM by Michael Croft
    Bio-IT World Speaking at the J.P. Morgan Healthcare Conference this afternoon, Francis deSouza, President and CEO of Illumina, unveiled the NovaSeq series, a new and scalable sequencing architecture, comprised of two instruments: the NovaSeq 5000 and NovaSeq 6000.
    Full story
  • Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline

    Jan 9, 2017, 19:15 PM by Michael Croft
    Forbes | What drugs is Moderna developing? It finally gives some details at JP Morgan.
    Full story
  • PatientsLikeMe Joins Wang's iCarbonX Digital Life Alliance Cornerstone

    Jan 9, 2017, 16:43 PM by Michael Croft
    Diagnostics World | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.
    Full story
  • Will Our Government’s Multi-Billion-Dollar Investment In Genome Science Pay Off?

    Jan 9, 2017, 15:51 PM by Michael Croft
    Pacific Standard | Though the medical benefits of genome science have been marginal thus far, the government's multi-billion-dollar investment could pay off with the right policy adjustments.
    Full story
  • Interference: A CRISPR Patent Dispute Roadmap

    Jan 9, 2017, 10:10 AM by Michael Croft

    Bio-IT World | An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.

    Full story
  • «
  • 311
  • 312
  • 313
  • 314
  • 315
  • 316 (current)
  • 317
  • 318
  • 319
  • 320
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy